SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-24-000741
Filing Date
2024-05-10
Accepted
2024-05-10 17:04:57
Documents
73
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q nwbo-20240331x10q.htm   iXBRL 10-Q 1844214
2 EX-31.1 nwbo-20240331xex31d1.htm EX-31.1 13053
3 EX-32.1 nwbo-20240331xex32d1.htm EX-32.1 9385
  Complete submission text file 0001410578-24-000741.txt   9634208

Data Files

Seq Description Document Type Size
4 EX-101.SCH nwbo-20240331.xsd EX-101.SCH 73117
5 EX-101.CAL nwbo-20240331_cal.xml EX-101.CAL 55867
6 EX-101.DEF nwbo-20240331_def.xml EX-101.DEF 353087
7 EX-101.LAB nwbo-20240331_lab.xml EX-101.LAB 510459
8 EX-101.PRE nwbo-20240331_pre.xml EX-101.PRE 485088
77 EXTRACTED XBRL INSTANCE DOCUMENT nwbo-20240331x10q_htm.xml XML 1952905
Mailing Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814
Business Address 4800 MONTGOMERY LANE SUITE 800 BETHESDA MD 20814 (240) 497-9024
NORTHWEST BIOTHERAPEUTICS INC (Filer) CIK: 0001072379 (see all company filings)

IRS No.: 943306718 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35737 | Film No.: 24935909
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)